Back to Trades
Total Value
$0
Filing Date
Jul 17, 2026
1 transactions
Trade Summary
On Jun 2, 2026, Donato Leslie E, Director, reported $0 of Keenova Therapeutics plc (NONE) across 1 transactions. The filing covers Ordinary Shares and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Keenova Therapeutics plc
- Ticker Symbol
- NONE
- CIK
- 0001567892
Insider Information
- Name
- Donato Leslie E
- Role
- Director
- Location
- BRIDGEWATER, NJ
Filing Details
- Filing Date
- Jul 17, 2026
- Transaction Date
- Jun 2, 2026
- Accession Number
- 0001104659-26-084773
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 2, 2026 | Ordinary Shares | 2,685 | — | Exercise | — |
| Jun 2, 2026 | Ordinary Shares | 619 | — | Tax Withholding | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 2, 2026 | NONE derivative | 2,197 | — | Disposition | — |
| Jun 2, 2026 | NONE derivative | 2,685 | — | Exercise | — |
Want live alerts when Donato Leslie E trades again?
Download Insider Trades to track NONE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU.
- (F2)The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market.
- (F3)The Reporting Person entered into an agreement with the Issuer pursuant to which the Reporting Person forfeited the right to receive 2,197 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the Reporting Person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest.
- (F4)The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders.
- (F5)The number of RSUs forfeited is based on a percentage.